Biotech

All Articles

Analysts dig into Avidity's DMD win, exposing nuances in information

.Avidity Biosciences pleased clients with stage 1/2 data in Duchenne muscular dystrophy (DMD) Friday...

Actinogen's cortisol blocker stops working stage 2 clinical depression study

.Actinogen Medical's cortisol blocker has actually overlooked the major endpoint of a phase 2 study ...

Bivictrix chooses going private only way to take ADC into clinic

.Antibody-drug conjugates (ADCs) have actually gone to the center of a lot of a billion-dollar biobu...

TPG bests up funds to $580M for expenditures throughout lifestyle sciences

.Possession manager TPG, which has sustained biotechs such as Sionna Therapies and Santa Clam Ana Bi...

Merck quits period 3 TIGIT test in lung cancer for futility

.Merck &amp Co.'s TIGIT system has endured an additional problem. Months after shuttering a phase 3 ...

After a challenging year, Exscientia folds up right into Recursion

.After a year described through pipe hairstyles, the variation of its CEO and discharges, Exscientia...

Cullinan, after $25M offer, hands back bispecific to Port

.Cullinan Therapy was actually wowed enough along with Port BioMed's bispecific immune system activa...

A deeper examine Intense Biotech's Tough 15

.In this particular full week's episode of "The Leading Line," our experts're diving right into Fier...

Lilly experiences period 2 failing of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's party celebrating the approval of Alzheimer's...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings and also ...